-
Je něco špatně v tomto záznamu ?
The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus
A. Janež, R. Ješe, M. Haluzík, M. Rizzo
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2007
PubMed Central
od 2018
Europe PubMed Central
od 2018
ProQuest Central
od 2018-01-01
Open Access Digital Library
od 2014-01-01
Health & Medicine (ProQuest)
od 2018-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2007
PubMed
36013528
DOI
10.3390/medicina58081061
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus 2. typu * epidemiologie MeSH
- lékaři * MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
- Evropa MeSH
- Itálie MeSH
Background and Objectives: The constantly increasing prevalence of type 2 diabetes mellitus (T2DM) and the advent of new treatment options have made management of T2DM patients more demanding. We aimed to (a) estimate the familiarity of general practitioners with novel T2DM treatment options, (b) determine whether a digital tool can aid in their treatment decisions and (c) demonstrate that an evidence-based digital clinical support tool can be made using an existing digital platform. Materials and methods: This proof-of-concept study consisted of two parts: We first conducted a simple online survey among general practitioners of three European countries to estimate their familiarity with novel T2DM treatment options and to determine whether they believe that a digital tool can aid in their T2DM treatment decisions. We then proceeded to develop a new digital tool that provides quick, evidence-based support for treatment of patients with T2DM using an existing digital platform. Results: The online survey was completed by 129/5278 physicians (94 from Italy, 22 from Czech Republic and 13 from Slovenia). Only 30.7% of all general practitioners reported to be either very or extremely familiar with novel T2DM treatments; the vast majority of participating general practitioners (82.8%) reported that they would find a digital clinical decision support tool for treating T2DM patients either very or extremely useful. A digital tool which features the characteristics deemed most important by the polled physicians was subsequently developed. Conclusions: The results of the online survey showed that familiarity of general practitioners with novel T2DM treatment options is relatively low and that there is a need for digital clinical decision support tools intended to facilitate treatment decisions in T2DM patients. We demonstrated that such a tool can easily be developed using an existing digital platform.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024894
- 003
- CZ-PrNML
- 005
- 20221031100601.0
- 007
- ta
- 008
- 221017s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/medicina58081061 $2 doi
- 035 __
- $a (PubMed)36013528
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Janež, Andrej $u Department of Endocrinology, Diabetes and Metabolic Disease, University Medical Centre Ljubljana, Zaloska 7, 1000 Ljubljana, Slovenia $u Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia $1 https://orcid.org/0000000265945254
- 245 14
- $a The Role of Physicians' Digital Tools in Pharmacological Management of Type 2 Diabetes Mellitus / $c A. Janež, R. Ješe, M. Haluzík, M. Rizzo
- 520 9_
- $a Background and Objectives: The constantly increasing prevalence of type 2 diabetes mellitus (T2DM) and the advent of new treatment options have made management of T2DM patients more demanding. We aimed to (a) estimate the familiarity of general practitioners with novel T2DM treatment options, (b) determine whether a digital tool can aid in their treatment decisions and (c) demonstrate that an evidence-based digital clinical support tool can be made using an existing digital platform. Materials and methods: This proof-of-concept study consisted of two parts: We first conducted a simple online survey among general practitioners of three European countries to estimate their familiarity with novel T2DM treatment options and to determine whether they believe that a digital tool can aid in their T2DM treatment decisions. We then proceeded to develop a new digital tool that provides quick, evidence-based support for treatment of patients with T2DM using an existing digital platform. Results: The online survey was completed by 129/5278 physicians (94 from Italy, 22 from Czech Republic and 13 from Slovenia). Only 30.7% of all general practitioners reported to be either very or extremely familiar with novel T2DM treatments; the vast majority of participating general practitioners (82.8%) reported that they would find a digital clinical decision support tool for treating T2DM patients either very or extremely useful. A digital tool which features the characteristics deemed most important by the polled physicians was subsequently developed. Conclusions: The results of the online survey showed that familiarity of general practitioners with novel T2DM treatment options is relatively low and that there is a need for digital clinical decision support tools intended to facilitate treatment decisions in T2DM patients. We demonstrated that such a tool can easily be developed using an existing digital platform.
- 650 12
- $a diabetes mellitus 2. typu $x epidemiologie $7 D003924
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a lékaři $7 D010820
- 651 _2
- $a Česká republika $7 D018153
- 651 _2
- $a Evropa $7 D005060
- 651 _2
- $a Itálie $7 D007558
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ješe, Rok $u Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia
- 700 1_
- $a Haluzík, Martin $u Diabetes Centre, Institute for Clinical and Experimental Medicine, Videnska 1958/9, 140 21 Praha, Czech Republic
- 700 1_
- $a Rizzo, Manfredi $u Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), School of Medicine, University of Palermo, 90100 Palermo, Italy $1 https://orcid.org/0000000295498504
- 773 0_
- $w MED00180386 $t Medicina $x 1648-9144 $g Roč. 58, č. 8 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36013528 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100559 $b ABA008
- 999 __
- $a ok $b bmc $g 1854548 $s 1176184
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 58 $c 8 $e 20220806 $i 1648-9144 $m Medicina $n Medicina (Kaunas) $x MED00180386
- LZP __
- $a Pubmed-20221017